E-cadherin (CDH1) is a cell adhesion molecule that coordi-nates key morphogenetic processes regulating cell growth, cell proliferation, and apoptosis. Loss of CDH1 is a trademark of the cellular event epithelial to mesenchymal transition, which increases the metastatic potential of malignant cells. PTEN is a tumor-suppressor gene commonly mutated in many human cancers, including endometrial cancer. In the mouse uterus, ablation of Pten induces epithelial hyperplasia, leading to endometrial carcinomas. However, loss of Pten alone does not affect longevity until around 5 mo. Similarly, conditional ablation of Cdh1 alone does not predispose mice to cancer. In this study, we characterized the impact of dual Cdh1 and Pten ablation (Cdh1d/d Ptend...
Epithelial to mesenchymal transition (EMT) is the process in which cells lose their epithelial struc...
Abstract Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor ...
TGF-β has a dichotomous function, acting as tumor suppressor in premalignant cells but as a tumor pr...
E-cadherin (CDH1) is a cell adhesion molecule that coordinates key morphogenetic processes regulatin...
E-&ndashcadherin (CDH1) is a cell adhesion molecule that coordinates key morphogenetic processes reg...
Mutation of the tumor suppressor Pten often leads to tumorigenesis in various organs including the u...
E–cadherin (CDH1) is a cell–cell adhesion molecule expressed in the epithelium to coordinate key mor...
Mutation of the tumor suppressor Pten often leads to tumorigenesis in various organs including the u...
Type II endometrial carcinomas (ECs) are estrogen independent, poorly differentiated tumors that beh...
E-cadherin (E-cadh), a member of the classic cadherins superfamily, plays an important role in epith...
SummaryInvasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to...
Signals from the tumor suppressors PTEN and LKB1 converge on mTOR to negatively regulate its functio...
Invasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to chemot...
PURPOSE: The relationship between endometrial carcinoma and cellular metabolism is unknown. In endom...
Aims: PTEN is a recently identified tumour suppressor inactivated in a wide variety of human cancer...
Epithelial to mesenchymal transition (EMT) is the process in which cells lose their epithelial struc...
Abstract Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor ...
TGF-β has a dichotomous function, acting as tumor suppressor in premalignant cells but as a tumor pr...
E-cadherin (CDH1) is a cell adhesion molecule that coordinates key morphogenetic processes regulatin...
E-&ndashcadherin (CDH1) is a cell adhesion molecule that coordinates key morphogenetic processes reg...
Mutation of the tumor suppressor Pten often leads to tumorigenesis in various organs including the u...
E–cadherin (CDH1) is a cell–cell adhesion molecule expressed in the epithelium to coordinate key mor...
Mutation of the tumor suppressor Pten often leads to tumorigenesis in various organs including the u...
Type II endometrial carcinomas (ECs) are estrogen independent, poorly differentiated tumors that beh...
E-cadherin (E-cadh), a member of the classic cadherins superfamily, plays an important role in epith...
SummaryInvasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to...
Signals from the tumor suppressors PTEN and LKB1 converge on mTOR to negatively regulate its functio...
Invasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to chemot...
PURPOSE: The relationship between endometrial carcinoma and cellular metabolism is unknown. In endom...
Aims: PTEN is a recently identified tumour suppressor inactivated in a wide variety of human cancer...
Epithelial to mesenchymal transition (EMT) is the process in which cells lose their epithelial struc...
Abstract Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor ...
TGF-β has a dichotomous function, acting as tumor suppressor in premalignant cells but as a tumor pr...